RecruitingNCT06566911

Voice Analysis for Monitoring Patients With Heart Failure

A Pilot Study on AI-Based Voice Analysis for Monitoring Patients Hospitalized With Acute Decompensated Heart Failure


Sponsor

Noah Labs

Enrollment

70 participants

Start Date

Jan 24, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Clinically diagnosed with Acutely Decompensated Heart Failure.
  • At least 18 years of age.

Exclusion Criteria8

  • Disabling mental diseases (e.g., Alzheimer's disease)
  • Clinically diagnosed chronic obstructive pulmonary disease (COPD)
  • Treatment in ICU or IMU
  • Dialysis treatment
  • Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.)
  • Neurodegenerative diseases
  • Pregnancy
  • Inability to provide consent

Locations(2)

Mayo Clinic

Rochester, Minnesota, United States

Deutsches Herzzentrum der Charité

Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06566911


Related Trials